These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18835148)

  • 21. Harm reduction ethics: a promising basis for drug policy.
    Miller P
    Drug Alcohol Rev; 2005 Nov; 24(6):553-4. PubMed ID: 16361213
    [No Abstract]   [Full Text] [Related]  

  • 22. Accountability and participation: how to overcome the tutelary character in the psychosocial care center for alcohol and drug users?
    Santos JMD; Baptista JÁ; Nasi C; Camatta MW
    Rev Gaucha Enferm; 2018 Nov; 39():e20180078. PubMed ID: 30517434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ushering in another harm reduction era? Discursive authenticity, drug policy and research.
    Hathaway AD
    Drug Alcohol Rev; 2005 Nov; 24(6):549-50. PubMed ID: 16361211
    [No Abstract]   [Full Text] [Related]  

  • 24. Legal aid works! Harm reduction and legal services in Poltava, Ukraine.
    Demchenko M
    HIV AIDS Policy Law Rev; 2007 Dec; 12(2-3):67-9. PubMed ID: 18459225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy.
    Elliott R; Csete J; Wood E; Kerr T
    Health Hum Rights; 2005; 8(2):104-38. PubMed ID: 17136905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consider legalising drugs despite UN treaties, says influential commission.
    Hurley R
    BMJ; 2016 Apr; 353():i2474. PubMed ID: 27130078
    [No Abstract]   [Full Text] [Related]  

  • 27. Harm reduction behaviors among young polysubstance users at raves.
    Fernández-Calderón F; Lozano-Rojas Ó; Rojas-Tejada A; Bilbao-Acedos I; Vidal-Giné C; Vergara-Moragues E; González-Saiz F
    Subst Abus; 2014; 35(1):45-50. PubMed ID: 24588292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harm reduction psychotherapy: extending the reach of traditional substance use treatment.
    Tatarsky A
    J Subst Abuse Treat; 2003 Dec; 25(4):249-56. PubMed ID: 14693253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advocating for a harm-minimization approach to drug education in Australian schools.
    Guzys D; Kendall S
    J Sch Nurs; 2006 Oct; 22(5):259-63. PubMed ID: 17172197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reducing the harm of "harm reduction".
    Beirness DJ; Notarandrea R; Jesseman R; Perron M
    Clin Pharmacol Ther; 2008 Apr; 83(4):523-5. PubMed ID: 18349874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug effects, performativity and the law.
    Race K
    Int J Drug Policy; 2011 Nov; 22(6):410-2. PubMed ID: 22056290
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug Policy and the Public Good: a summary of the book.
    Drugs and Public Policy Group
    Addiction; 2010 Jul; 105(7):1137-45. PubMed ID: 20642498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Six-month outcomes among socially marginalized alcohol and drug users attending a drop-in center allowing alcohol consumption.
    Grazioli VS; Collins SE; Paroz S; Graap C; Daeppen JB
    Int J Drug Policy; 2017 Mar; 41():65-73. PubMed ID: 28104548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in attitudes and knowledge of problem drug use and harm reduction among a community cohort in Kabul, Afghanistan.
    Todd CS; Stanekzai MR; Nasir A; Fiekert K; Orr MG; Strathdee SA; Vlahov D
    East Mediterr Health J; 2016 Jun; 22(3):183-92. PubMed ID: 27334075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding post 9/11 drug control policy and politics in Central Asia.
    Latypov A
    Int J Drug Policy; 2009 Sep; 20(5):387-91. PubMed ID: 19121928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The most vulnerable addicts are forgotten].
    Halldin J
    Lakartidningen; 2011 Jun 29-Jul 19; 108(26-28):1379. PubMed ID: 21848191
    [No Abstract]   [Full Text] [Related]  

  • 37. Beyond human rights and public health: citizenship issues in harm reduction.
    Chen JS
    Int J Drug Policy; 2011 May; 22(3):184-8. PubMed ID: 21242083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harm reduction drug policies and practice: international developments and domestic initiatives. Overview of a symposium. March 22, 1995.
    Drucker E; Hantman JA
    Bull N Y Acad Med; 1995; 72(2):335-8. PubMed ID: 10101373
    [No Abstract]   [Full Text] [Related]  

  • 39. Being in control? A thematic content analysis of 14 in-depth interviews with 2,4-dinitrophenol users.
    Ainsworth NP; Vargo EJ; Petróczi A
    Int J Drug Policy; 2018 Feb; 52():106-114. PubMed ID: 29331928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harm Reduction Works: Evidence and Inclusion in Drug Policy and Advocacy.
    Klein A
    Health Care Anal; 2020 Dec; 28(4):404-414. PubMed ID: 33079317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.